Loading clinical trials...
Loading clinical trials...
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Conditions
Interventions
Lasmiditan
Placebo
Locations
152
United States
Central Research Associates
Birmingham, Alabama, United States
Rehabilitation & Neurological Services
Huntsville, Alabama, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Perseverance Research Center
Scottsdale, Arizona, United States
Center for Neurosciences
Tucson, Arizona, United States
Arkansas Children's
Little Rock, Arkansas, United States
Start Date
June 15, 2020
Primary Completion Date
November 12, 2025
Completion Date
November 12, 2025
Last Updated
March 10, 2026
NCT06735833
NCT06241313
NCT06641466
NCT07018713
NCT04715685
NCT07476053
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions